Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare TSE:HSM CVE:MDX NYSE:PHM CVE:VPT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHSMHelius Medical TechnologiesC$0.00C$14.26▼C$40.00C$42.54MN/A3,578 shs930 shsMDXMedX HealthC$0.05C$0.06C$0.05▼C$0.10C$16.40M0.43377681,141 shs72,000 shsPHMPulteGroup$118.00+2.5%$123.74$95.20▼$144.49$22.48B1.231.90 million shs1.40 million shsVPTVentriPoint DiagnosticsC$0.13-13.3%C$0.11C$0.08▼C$0.19C$24.40M-0.918142133,635 shs413,726 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHSMHelius Medical Technologies0.00%0.00%0.00%0.00%0.00%MDXMedX Health0.00%0.00%-8.33%-8.33%-26.67%PHMPulteGroup0.00%-7.01%+1.80%-8.26%+14.29%VPTVentriPoint Diagnostics0.00%+65.00%+43.48%+37.50%+17.86%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHSMHelius Medical TechnologiesC$0.00C$14.26▼C$40.00C$42.54MN/A3,578 shs930 shsMDXMedX HealthC$0.05C$0.06C$0.05▼C$0.10C$16.40M0.43377681,141 shs72,000 shsPHMPulteGroup$118.00+2.5%$123.74$95.20▼$144.49$22.48B1.231.90 million shs1.40 million shsVPTVentriPoint DiagnosticsC$0.13-13.3%C$0.11C$0.08▼C$0.19C$24.40M-0.918142133,635 shs413,726 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHSMHelius Medical Technologies0.00%0.00%0.00%0.00%0.00%MDXMedX Health0.00%0.00%-8.33%-8.33%-26.67%PHMPulteGroup0.00%-7.01%+1.80%-8.26%+14.29%VPTVentriPoint Diagnostics0.00%+65.00%+43.48%+37.50%+17.86%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHSMHelius Medical Technologies 0.00N/AN/AN/AMDXMedX Health 0.00N/AN/AN/APHMPulteGroup 2.59Moderate Buy$140.7119.25% UpsideVPTVentriPoint Diagnostics 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest MDX, PHM, HSM, and VPT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/27/2026PHMPulteGroup Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (B-) ➝ Hold (C)4/24/2026PHMPulteGroup UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$159.00 ➝ $162.004/24/2026PHMPulteGroup Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$132.00 ➝ $140.004/24/2026PHMPulteGroup EvercoreSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$146.00 ➝ $151.004/24/2026PHMPulteGroup The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$133.00 ➝ $142.004/24/2026PHMPulteGroup CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$136.00 ➝ $138.004/20/2026PHMPulteGroup Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$145.00 ➝ $140.004/16/2026PHMPulteGroup Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$170.00 ➝ $150.004/13/2026PHMPulteGroup Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold4/13/2026PHMPulteGroup EvercoreSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeIn-Line ➝ Outperform$146.00(Data available from 5/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHSMHelius Medical TechnologiesC$477K0.00N/A5.71C$3.61 per share0.00MDXMedX HealthC$522.90K31.36C$0.00 per share60.00C($0.03) per share-1.67PHMPulteGroup$16.83B1.34$12.47 per share9.46$67.52 per share1.75VPTVentriPoint DiagnosticsC$175.62K138.91C$0.02 per share5.53C($0.03) per share-4.67Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHSMHelius Medical TechnologiesN/A-C$11.02N/AN/AN/AN/AN/AN/AN/AMDXMedX Health-C$3.82M-C$0.01N/AN/AN/AN/AN/A-220.68%N/APHMPulteGroup$2.22B$10.3411.4110.591.5112.14%16.41%11.75%N/AVPTVentriPoint Diagnostics-C$5.25M-C$0.03N/AN/AN/A-2,311.82%106.68%-136.72%N/ALatest MDX, PHM, HSM, and VPT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/23/2026Q1 2026PHMPulteGroup$1.80$1.79-$0.01$1.79$3.40 billion$3.41 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthHSMHelius Medical TechnologiesN/AN/AN/AN/AN/AMDXMedX HealthN/AN/AN/AN/AN/APHMPulteGroup$1.040.88%+12.97%10.06%7 YearsVPTVentriPoint DiagnosticsN/AN/AN/AN/AN/ALatest MDX, PHM, HSM, and VPT DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/29/2026PHMPulteGroupquarterly$0.260.86%6/16/20266/16/20267/2/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHSMHelius Medical Technologies0.744.203.58MDXMedX HealthN/A0.100.05PHMPulteGroup0.140.940.94VPTVentriPoint Diagnostics-50.430.056.67Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHSMHelius Medical TechnologiesN/AMDXMedX Health3.04%PHMPulteGroup89.90%VPTVentriPoint Diagnostics4.06%Insider OwnershipCompanyInsider OwnershipHSMHelius Medical TechnologiesN/AMDXMedX Health6.23%PHMPulteGroup0.75%VPTVentriPoint Diagnostics2.13%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHSMHelius Medical Technologies192.32 millionN/ANot OptionableMDXMedX HealthN/A327.93 millionN/ANot OptionablePHMPulteGroup6,506190.49 million189.06 millionOptionableVPTVentriPoint Diagnostics147,000187.66 millionN/ANot OptionableMDX, PHM, HSM, and VPT HeadlinesRecent News About These CompaniesVentripoint to Exhibit at the 59th Annual Meeting of the Association for European Paediatric and Congenital CardiologyMay 4 at 1:39 PM | finance.yahoo.comWhy Medtech Giants Are Quietly Paying Up for AI DiagnosticsApril 29, 2026 | tmcnet.comThe Quiet Rule Change Tilting $10B Toward Medtech's Most Validated PlatformsApril 29, 2026 | tmcnet.comThe Infrastructure Play Hiding in Plain Sight Across Cardiac CareApril 16, 2026 | financialpost.comFThe Quiet Shift Replacing Million-Dollar Heart Scanners With SoftwareApril 16, 2026 | financialpost.comFVentriPoint Diagnostics Ltd.April 8, 2026 | marketwatch.comThe Hidden Crisis Driving Billions into Cardiac Care InnovationMarch 27, 2026 | baystreet.caVentripoint Taps LG Consulting to Drive VMS+ Rollout in Northern CaliforniaMarch 13, 2026 | theglobeandmail.com(CNW) Hospital Networks Turn to AI-Enhanced Cardiac Imaging to Cut Costs and Improve OutcomesMarch 4, 2026 | marketwatch.comHospital Networks Turn to AI-Enhanced Cardiac Imaging to Cut Costs and Improve OutcomesMarch 3, 2026 | tmcnet.comCEO.CA's Inside the Boardroom: Why Ventripoint is the Most Profitable "Bolt-On" Solution for Modern HospitalsFebruary 26, 2026 | finance.yahoo.comAI-Native Data Core Triggers Multi-Trillion Dollar Healthcare Structural ShiftJanuary 29, 2026 | tmcnet.comAI Medical Imaging Revolution: Software-Native Tech Disrupts $45B MarketJanuary 27, 2026 | newswire.caThe 2026 Healthcare Reset: Subscription Economics Meets MRI-Grade AI PrecisionJanuary 27, 2026 | baystreet.caBedside Breakthrough: AI Brings MRI-Precision to Every ClinicJanuary 16, 2026 | tmcnet.comAI Diagnostics: The End of the High-Cost Imaging EraJanuary 16, 2026 | financialpost.comFMedical Breakthroughs: 5 AI Innovators Redefining What's PossibleDecember 19, 2025 | theglobeandmail.comVentripoint hires Summit Sciences to build ROI models for AI cardiac imaging platformDecember 18, 2025 | msn.comAI Diagnostics Hit Critical Mass as Hospitals Race to Cut CostsDecember 12, 2025 | wowktv.comWFinancial Pressure Turns Healthcare AI From Pilots Into ProfitsDecember 12, 2025 | baystreet.caNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesWith Nike Shares Near a 12-Year Low, Is Now the Time to Be Brave?By Sam Quirke | April 12, 20263 Dividend Aristocrats Whose Yields Can Help Combat InflationBy Chris Markoch | April 9, 2026The War Won't Last Forever: 3 Stocks That Could Lead the RecoveryBy Bridget Bennett | April 8, 2026Homebuilder Earnings: D.R. Horton Sticks Out as Pulte & NVR Sales TankBy Leo Miller | April 27, 2026Netflix, Pulte, and Mobileye Are Buying Their Own Dips—Should You?By Leo Miller | May 4, 2026MDX, PHM, HSM, and VPT Company DescriptionsHelius Medical Technologies TSE:HSMHelius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-implantable investigational medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.MedX Health CVE:MDXC$0.05 0.00 (0.00%) As of 03:08 PM EasternMedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market. It operates DermSecure telemedicine platform that enables the web-based operation of its SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients' mole and lesion images along with other relevant patient information can be connected to specialist physicians for remote assessment. The company was incorporated in 1999 and is headquartered in Mississauga, Canada.PulteGroup NYSE:PHM$118.00 +2.85 (+2.47%) Closing price 03:59 PM EasternExtended Trading$118.98 +0.98 (+0.83%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.PulteGroup, Inc., through its subsidiaries, primarily engages in the homebuilding business in the United States. It acquires and develops land primarily for residential purposes; and constructs housing on such land. The company also offers various home designs, including single-family detached, townhomes, condominiums, and duplexes under the Centex, Pulte Homes, Del Webb, DiVosta Homes, John Wieland Homes and Neighborhoods, and American West brand names. In addition, the company arranges financing through the origination of mortgage loans primarily for homebuyers; sells the servicing rights for the originated loans; and provides title insurance policies, and examination and closing services to homebuyers. PulteGroup, Inc. was founded in 1950 and is headquartered in Atlanta, Georgia.VentriPoint Diagnostics CVE:VPTC$0.13 -0.02 (-13.33%) As of 03:49 PM EasternVentripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. The company also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients. Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir Drops After a Blowout Q1—What Investors Should Know Shopify’s Valuation Crisis Creates Opportunity in 2026 onsemi Stock Dips After Earnings: Why the Dip Is Buyable TSLA: 3 Reasons the Stock Could Hit $400 in May Nebius Breaks Out to All-Time Highs—Here's What's Driving It. 3 Reasons Analysts Love DexCom The Great Chip Divide: AI Chip War Pivots from Hype to Execution Atomic Dividends: Big Tech's New Energy Bet Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
